US Stock MarketDetailed Quotes

HGV Hilton Grand Vacations

Watchlist
  • 42.900
  • +0.400+0.94%
Close Feb 28 16:00 ET
  • 42.900
  • 0.0000.00%
Post 16:20 ET
4.15BMarket Cap95.33P/E (TTM)

Hilton Grand Vacations Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Hilton Grand Vacations Q4 2024 Earnings Date

Currency：USDFeb 27, 2025

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
1.28B
1.28B
+2.49M
Beat Est.
+25.76%
+26.01%
+0.19%
EPS
0.57
0.19
-0.38
Miss Est.
-7.89%
-69.35%
-66.73%
Analyst Rating
Buy

Mar 1, 2025

Hilton Grand Vacations Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 5 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.362B--
--2025/Q1-- / 1.233B--
Feb 27, 20252024/Q41.284B / 1.282B--
Nov 7, 20242024/Q31.306B / 1.294B--
Aug 8, 20242024/Q21.235B / 1.338B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 1.362B--
--2025/Q1-- / 1.233B--
Feb 27, 20252024/Q41.284B / 1.282B--
Nov 7, 20242024/Q31.306B / 1.294B--
Aug 8, 20242024/Q21.235B / 1.338B--

Unlock Free Earnings Estimates

Hilton Grand Vacations Earnings Reports

  • Hilton Grand Vacations | 10-Q: Q3 2024 Earnings Report

    Nov 7, 2024 15:13 ET

  • Hilton Grand Vacations | 10-Q: Q2 2024 Earnings Report

    Aug 8, 2024 14:24 ET

  • Hilton Grand Vacations | 10-Q: Q1 2024 Earnings Report

    May 9, 2024 15:08 ET

  • Hilton Grand Vacations | 10-K: FY2023 Annual Report

    Feb 29, 2024 15:44 ET

    • Read more

    Trending Stocks
    Best Growth Stocks Best Growth Stocks

    Spot stocks with huge growth potential and solid financial standing. Spot stocks with huge growth potential and solid financial standing.

    Symbol Mini Chart % Chg
    Cars.com
    CARS
    +9.73%
    Lantheus
    LNTH
    +2.55%
    Halozyme Therapeutics
    HALO
    +2.51%
    DOMINOS PIZZA ENTERPRISES LIMITED UNSP ADR EACH REPR 0.5 ORD SHS
    DMZPY
    +2.27%
    Collegium Pharmaceutical
    COLL
    +2.22%

    Unlock the Full List

    Analysis

    Analyst Rating

    Updated: Mar 1, 2025

    Buy

    • Buy

      66.67%

    • Hold

      16.67%

    • Sell

      16.67%

    Price Target

    No Data